[1] |
Jin X, Wu H, Smith H. APOBEC3G levels predict rates of progression to AIDS[J]. Retrovirology, 2007,4:20. doi: 10.1186/1742⁃4690⁃4⁃20.
|
[2] |
Jin X, Brooks A, Chen H, et al. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia[J]. J Virol, 2005,79(17):11513⁃11516. doi: 10. 1128/JVI.79.17.11513⁃11516.2005.
|
[3] |
Heinzelmann A, Stein S, Köhl U, et al. Regulation of HIV⁃1 infection in cells derived from purified CD34+ cells through manipulation of APOBEC3G expression[J]. Curr HIV Res, 2010,8(7):554⁃563.
|
[4] |
Chen K, Huang J, Zhang C, et al. Alpha interferon potently enhances the anti⁃human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells[J]. J Virol, 2006,80(15):7645⁃7657. doi: 10.1128/JVI.00206⁃06.
|
[5] |
Tanaka Y, Marusawa H, Seno H, et al. Anti⁃viral protein APOBEC3G is induced by interferon⁃alpha stimulation in human hepatocytes[J]. Biochem Biophys Res Commun, 2006,341(2):314⁃319. doi: 10.1016/j.bbrc.2005.12.192.
|
[6] |
Peng G, Lei KJ, Jin W, et al. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon⁃induced anti⁃HIV⁃1 activity[J]. J Exp Med, 2006,203(1):41⁃46. doi: 10.1084/jem.20051512.
|
[7] |
Boshoff C, Endo Y, Collins PD, et al. Angiogenic and HIV⁃inhibitory functions of KSHV⁃encoded chemokines[J]. Science, 1997,278(5336):290⁃294.
|
[8] |
Kledal TN, Rosenkilde MM, Coulin F, et al. A broad⁃spectrum chemokine antagonist encoded by Kaposi′s sarcoma⁃associated herpesvirus[J]. Science, 1997,277(5332):1656⁃1659.
|
[9] |
Cherqui S, Kingdon KM, Thorpe C, et al. Lentiviral gene delivery of vMIP⁃Ⅱ to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo[J]. Mol Ther, 2007,15(7):1264⁃1272. doi: 10.1038/sj.mt.6300183.
|
[10] |
Dawson DA, Hardy AM. AIDS knowledge and attitudes of hispanic Americans. Provisional data from the 1988 National Health Interview Survey[J]. Adv Data, 1989,(166):1⁃22.
|
[11] |
Chandriani S, Ganem D. Host transcript accumulation during lytic KSHV infection reveals several classes of host responses[J]. PLoS One, 2007,2(8):e811. doi: 10.1371/journal.pone. 0000811.
|
[12] |
Russell RA, Moore MD, Hu WS, et al. APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV⁃1 replication results in levels of G⁃to⁃A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA[J]. Retrovirology, 2009,6:16. doi: 10.1186/1742⁃4690⁃6⁃16.
|
[13] |
Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements[J]. Annu Rev Immunol, 2008,26:317⁃353. doi: 10.1146/annurev.immunol.26.021607.090350.
|
[14] |
Chen H, Wang LW, Huang YQ, et al. Interferon⁃alpha induces high expression of APOBEC3G and STAT⁃1 in vitro and in vivo[J]. Int J Mol Sci, 2010,11(9):3501⁃3512. doi: 10.3390/ijms 11093501.
|
[15] |
Liu MQ, Zhao M, Kong WH, et al. Combination antiretroviral therapy (cART) restores HIV⁃1 infection⁃mediated impairment of JAK⁃STAT signaling pathway[J]. Oncotarget, 2017,8(14):22524⁃22533. doi: 10.18632/oncotarget.15121.
|
[16] |
Miao Q, Ku AT, Nishino Y, et al. Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2[J]. Nat Commun, 2014,5:4088. doi: 10.1038/ncomms5088.
|